Literature DB >> 10608850

Potentiation of cell migration by adhesion-dependent cooperative signals from the GTPase Rac and Raf kinase.

J Leng1, R L Klemke, A C Reddy, D A Cheresh.   

Abstract

The small GTPase Rac is thought to regulate cell movement by influencing actin cytoskeletal organization and membrane ruffling. However, cell migration also depends on the activation of mitogen-activated protein kinase (MAPK), which can regulate myosin motor function, an event critical for cell contraction. Evidence is provided that, during active cell adhesion to the extracellular matrix, Rac potentiates the MAPK pathway and influences cell migration by selectively synergizing with Raf kinase but not with Ras or MAPK kinase. In fact, the synergy between Rac and Raf kinase increases the chemotactic sensitivity of cells to epidermal growth factor by 1000-fold. Therefore, the role of Rac in cell migration not only depends on its ability to regulate actin cytoskeletal organization but also on its capacity to potentiate chemokine activation of MAPK in a manner that depends on active cell adhesion to the extracellular matrix.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10608850     DOI: 10.1074/jbc.274.53.37855

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Inhibitory regulation of Rac activation, membrane ruffling, and cell migration by the G protein-coupled sphingosine-1-phosphate receptor EDG5 but not EDG1 or EDG3.

Authors:  H Okamoto; N Takuwa; T Yokomizo; N Sugimoto; S Sakurada; H Shigematsu; Y Takuwa
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

2.  R-Ras controls membrane protrusion and cell migration through the spatial regulation of Rac and Rho.

Authors:  Michele A Wozniak; Lina Kwong; David Chodniewicz; Richard L Klemke; Patricia J Keely
Journal:  Mol Biol Cell       Date:  2004-11-03       Impact factor: 4.138

3.  Keratinocyte-derived laminin-332 promotes adhesion and migration in melanocytes and melanoma.

Authors:  Heesung Chung; Eun-Kyung Suh; Inn-Oc Han; Eok-Soo Oh
Journal:  J Biol Chem       Date:  2011-02-24       Impact factor: 5.157

4.  The MEK1 scaffolding protein MP1 regulates cell spreading by integrating PAK1 and Rho signals.

Authors:  Ashok Pullikuth; Evangeline McKinnon; Hans-Joerg Schaeffer; Andrew D Catling
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

5.  Resveratrol and estradiol exert disparate effects on cell migration, cell surface actin structures, and focal adhesion assembly in MDA-MB-231 human breast cancer cells.

Authors:  Nicolas G Azios; Suranganie F Dharmawardhane
Journal:  Neoplasia       Date:  2005-02       Impact factor: 5.715

6.  SUMOylation of RhoGDIα is required for its repression of cyclin D1 expression and anchorage-independent growth of cancer cells.

Authors:  Zipeng Cao; Xueyong Li; Jingxia Li; Beipei Kang; Jingyuan Chen; Wenjing Luo; Chuanshu Huang
Journal:  Mol Oncol       Date:  2013-12-03       Impact factor: 6.603

7.  Claudin-7 is frequently overexpressed in ovarian cancer and promotes invasion.

Authors:  Neetu Dahiya; Kevin G Becker; William H Wood; Yongqing Zhang; Patrice J Morin
Journal:  PLoS One       Date:  2011-07-15       Impact factor: 3.240

8.  Cortactin localization to sites of actin assembly in lamellipodia requires interactions with F-actin and the Arp2/3 complex.

Authors:  S A Weed; A V Karginov; D A Schafer; A M Weaver; A W Kinley; J A Cooper; J T Parsons
Journal:  J Cell Biol       Date:  2000-10-02       Impact factor: 10.539

9.  Phosphorylation of p130Cas initiates Rac activation and membrane ruffling.

Authors:  Alok Sharma; Bruce J Mayer
Journal:  BMC Cell Biol       Date:  2008-09-15       Impact factor: 4.241

10.  PAK1 phosphorylation of MEK1 regulates fibronectin-stimulated MAPK activation.

Authors:  Jill K Slack-Davis; Scott T Eblen; Maja Zecevic; Scott A Boerner; Adel Tarcsafalvi; H Bruce Diaz; Mark S Marshall; Michael J Weber; J Thomas Parsons; Andrew D Catling
Journal:  J Cell Biol       Date:  2003-07-21       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.